What is the most recent FDA action against Integra LifeSciences Corp. (NeuroSciences)?

The most recent FDA event Argus HQ has on file for Integra LifeSciences Corp. (NeuroSciences) is dated 2026-05-20, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Integra LifeSciences Corp. (NeuroSciences) automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Integra LifeSciences Corp. (NeuroSciences) is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Integra LifeSciences Corp. (NeuroSciences)?

8 total: 0 warning letters, 8 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Integra LifeSciences Corp. (NeuroSciences)?

July 15, 2026. Argus HQ ingests new FDA enforcement records daily.

Integra LifeSciences Corp. (NeuroSciences)'s Complete FDA Record

FDA action counts

Total FDA actions	8
Warning letters	0
Recalls	8
Approval records	0
Form 483 inspection citations	0
Most recent action	July 15, 2026

The short version: Argus HQ has recorded 7 FDA events for Integra LifeSciences Corp. (NeuroSciences): 0 warning letters, 7 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-04-22 to 2026-05-20. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Enforcement history

On 2026-04-22, Argus HQ recorded a FDA recall for Integra LifeSciences Corp. (NeuroSciences), rated "high" severity in Argus HQ's classification: Integra LifeSciences Corp. (NeuroSciences) — Class II recall: Cytal Wound Matrix 2-Layer 5x5 cm. Product ID: WSM0505. An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for Integra LifeSciences Corp. (NeuroSciences), rated "high" severity in Argus HQ's classification: Integra LifeSciences Corp. (NeuroSciences) — Class II recall: Cytal Burn Matrix 7x10 cm. Product ID: BMM0710. An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for Integra LifeSciences Corp. (NeuroSciences), rated "high" severity in Argus HQ's classification: Integra LifeSciences Corp. (NeuroSciences) — Class II recall: Cytal Burn Matrix 10x15 cm. Product ID: BMM1015. An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for Integra LifeSciences Corp. (NeuroSciences), rated "high" severity in Argus HQ's classification: Integra LifeSciences Corp. (NeuroSciences) — Class II recall: Cytal Wound Matrix 2-Layer 7x10 cm. Product ID: WSM0710. An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for Integra LifeSciences Corp. (NeuroSciences), rated "high" severity in Argus HQ's classification: Integra LifeSciences Corp. (NeuroSciences) — Class II recall: Cytal Wound Matrix 2-Layer 10x15 cm. Product ID: WSM1015. An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Integra LifeSciences Corp. (NeuroSciences), rated "high" severity in Argus HQ's classification: Integra LifeSciences Corp. (NeuroSciences) — Class II recall: CUSA Clarity C7000 Console, Software Version: 2.1.1.909. Ultrasonic surgical asp… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-05-20, Argus HQ recorded a FDA recall for Integra LifeSciences Corp. (NeuroSciences), rated "high" severity in Argus HQ's classification: Integra LifeSciences Corp. (NeuroSciences) — Class II recall: Codman CerebroFlo EVD Catheter with Endexo Technology. Contains 5 sets. Product… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. In total, Integra LifeSciences Corp. (NeuroSciences) has 7 FDA events on file with Argus HQ across the sources Argus HQ currently tracks (FDA Warning Letters, recalls, drug/biologic approvals, and Form 483 inspection observations).

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Integra LifeSciences Corp. (NeuroSciences) has 7 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

What is the most recent FDA action against Integra LifeSciences Corp. (NeuroSciences)?: The most recent FDA event Argus HQ has on file for Integra LifeSciences Corp. (NeuroSciences) is dated 2026-05-20, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Integra LifeSciences Corp. (NeuroSciences) automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Integra LifeSciences Corp. (NeuroSciences) is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Integra LifeSciences Corp. (NeuroSciences)?: 8 total: 0 warning letters, 8 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Integra LifeSciences Corp. (NeuroSciences)?: July 15, 2026. Argus HQ ingests new FDA enforcement records daily.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Jul 15, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Integra LifeSciences Corp. (NeuroSciences)'s Complete FDA Record. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/integra-lifesciences-corp-neurosciences

MLA

"Integra LifeSciences Corp. (NeuroSciences)'s Complete FDA Record." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/integra-lifesciences-corp-neurosciences.

Chicago

Argus HQ Research. "Integra LifeSciences Corp. (NeuroSciences)'s Complete FDA Record." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/company/integra-lifesciences-corp-neurosciences.

BibTeX

@misc{argushq_argushq_ai_company_integra_lifesciences_corp_neurosciences_2026,
  title = {Integra LifeSciences Corp. (NeuroSciences)'s Complete FDA Record},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/integra-lifesciences-corp-neurosciences},
  note = {Accessed: August 27, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗